BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

Income Statement

Follow revenue through to earnings.

Revenue

$47.48M

FY 2025 · Annual

-84.3% YoY

Operating Income

-$689,147.00

FY 2025 · Annual

Net Income

-$6.58M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.34M6.88M16.69M301.83M47.48M
Cost of Revenue1.47M881.75K1.26M13.75M3.26M
Gross Profit2.87M5.99M15.42M287.86M44.22M
Gross Margin66.0%87.2%92.4%95.4%93.1%
Research & Development119.65K123.31K342K1.91M7.09M
Selling, General & Admin4.19M10.21M22.63M254.75M37.82M
Operating Expenses4.47M10.67M23.2M256.66M44.91M
Depreciation & Amortization283.9K243.42K229.02K293.22K219.42K
EBITDA(602K)(6.52M)(7.55M)31.49M(469.73K)
EBITDA Margin-13.9%-94.8%-45.3%10.4%-1.0%
Operating Income(1.61M)(4.68M)(7.78M)31.2M(689.15K)
Operating Margin-37.0%-68.1%-46.6%10.3%-1.5%
Interest Income0000413.85K
Interest Expense525.88K468.15K700.33K587.22K0
Other Income / Expenses193.93K(2.55M)(704.02K)(587.22K)299.5K
Income Before Tax(1.41M)(7.11M)(8.48M)30.61M(389.65K)
Pre-Tax Margin-32.5%-103.5%-50.8%10.1%-0.8%
Income Tax Expense000(1.27M)6.19M
Net Income(1.45M)(7.07M)(8.48M)31.88M(6.58M)
Net Margin-33.3%-102.9%-50.8%10.6%-13.9%
EPS (Basic)(0.12)(0.62)(0.62)1.95(0.39)
EPS (Diluted)(0.12)(0.62)(0.62)1.47(0.39)
Weighted Avg Shares11.69M11.41M13.71M16.37M16.73M
Weighted Avg Shares (Diluted)11.69M11.41M13.71M21.7M16.73M

BSEM Earnings Waterfall · TTM

NASDAQ:BSEM · Revenue to Net Income

Key Ratios

EPS$-1.68
Gross Margin75.6%
Net Margin-59.2%
P/E Ratio5.2
P/S Ratio6.3

Analysis

-$60.3M of revenue converted into -$28.3M of net income for the selected period. Gross margin is 75.6% and net margin is -59.2%, showing how much revenue survives after costs and taxes. EPS is $-1.68, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-1S-1 filingSep 18, 2026
8-KCurrent reportSep 18, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

How much revenue does BSEM generate?

BioStem Technologies, Inc. (BSEM) reported $47.48M of revenue in fiscal 2025.

Is BSEM profitable?

BioStem Technologies, Inc. (BSEM) reported -$6.58M of net income, with a net margin of -13.9%.